Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 2
1948 2
1952 2
1954 1
1956 1
1958 1
1966 1
1968 2
1969 1
1971 2
1972 2
1978 1
1979 1
1980 1
1981 1
1982 1
1983 1
1984 2
1985 2
1986 2
1987 3
1988 1
1989 2
1990 3
1991 1
1992 1
1993 3
1994 3
1995 3
1996 4
1997 2
1998 4
1999 1
2000 1
2001 1
2002 1
2003 6
2004 2
2005 1
2006 3
2007 5
2008 3
2009 5
2010 7
2011 8
2012 9
2013 3
2014 7
2015 5
2016 9
2017 13
2018 12
2019 19
2020 15
2021 16
2022 8
2023 7
2024 7
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
[18F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration.
Blazhenets G, Soleimani-Meigooni DN, Thomas W, Mundada N, Brendel M, Vento S, VandeVrede L, Heuer HW, Ljubenkov P, Rojas JC, Chen MK, Amuiri AN, Miller Z, Gorno-Tempini ML, Miller BL, Rosen HJ, Litvan I, Grossman M, Boeve B, Pantelyat A, Tartaglia MC, Irwin DJ, Dickerson BC, Baker SL, Boxer AL, Rabinovici GD, La Joie R. Blazhenets G, et al. Among authors: baker sl. J Nucl Med. 2023 Dec 1;64(12):1980-1989. doi: 10.2967/jnumed.123.265856. J Nucl Med. 2023. PMID: 37918868 Free PMC article.
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome.
VandeVrede L, La Joie R, Thijssen EH, Asken BM, Vento SA, Tsuei T, Baker SL, Cobigo Y, Fonseca C, Heuer HW, Kramer JH, Ljubenkov PA, Rabinovici GD, Rojas JC, Rosen HJ, Staffaroni AM, Boeve BF, Dickerson BC, Grossman M, Huey ED, Irwin DJ, Litvan I, Pantelyat AY, Tartaglia MC, Dage JL, Boxer AL. VandeVrede L, et al. Among authors: baker sl. JAMA Neurol. 2023 May 1;80(5):495-505. doi: 10.1001/jamaneurol.2023.0488. JAMA Neurol. 2023. PMID: 37010841 Free PMC article.
Metacognition, cortical thickness, and tauopathy in aging.
Zhuang K, Chen X, Cassady KE, Baker SL, Jagust WJ. Zhuang K, et al. Among authors: baker sl. Neurobiol Aging. 2022 Oct;118:44-54. doi: 10.1016/j.neurobiolaging.2022.06.007. Epub 2022 Jun 25. Neurobiol Aging. 2022. PMID: 35868093 Free PMC article.
Erythrocytes as carriers of immunoglobulin-based therapeutics.
Ji W, Smith PN, Koepsel RR, Andersen JD, Baker SL, Zhang L, Carmali S, Myerson JW, Muzykantov V, Russell AJ. Ji W, et al. Among authors: baker sl. Acta Biomater. 2020 Jan 1;101:422-435. doi: 10.1016/j.actbio.2019.10.027. Epub 2019 Oct 25. Acta Biomater. 2020. PMID: 31669698
Individuals with Alzheimer's disease and low tau burden: Characteristics and implications.
Landau SM, Lee J, Murphy A, Ward TJ, Harrison TM, Baker SL, DeCarli C, Harvey D, Tosun D, Weiner MW, Koeppe RA, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative. Landau SM, et al. Among authors: baker sl. Alzheimers Dement. 2024 Mar;20(3):2113-2127. doi: 10.1002/alz.13609. Epub 2024 Jan 19. Alzheimers Dement. 2024. PMID: 38241084 Free PMC article.
Evaluation of [18F]-JNJ-64326067-AAA tau PET tracer in humans.
Baker SL, Provost K, Thomas W, Whitman AJ, Janabi M, Schmidt ME, Timmers M, Kolb HC, Rabinovici GD, Jagust WJ. Baker SL, et al. J Cereb Blood Flow Metab. 2021 Dec;41(12):3302-3313. doi: 10.1177/0271678X211031035. Epub 2021 Jul 14. J Cereb Blood Flow Metab. 2021. PMID: 34259071 Free PMC article. Clinical Trial.
205 results